IS7477A - Aðferð við framleiðslu sýrusalts af gemifloxasíni - Google Patents

Aðferð við framleiðslu sýrusalts af gemifloxasíni

Info

Publication number: IS7477A
Authority: IS; Iceland
Prior art keywords: gemifloxacin; production; acid salt; salt; acid
Prior art date: 2002-04-08

Application number

IS7477A

Other languages

English (en)

Other versions

IS2731B (is

Inventor

Choi Hoon

Choi Sang-Chul

Nam Do-Hyun

Choi Bo-Seung

Original Assignee

Lg Life Sciences Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-08

Filing date

2004-09-30

Publication date

2004-09-30

2004-09-30 Application filed by Lg Life Sciences Ltd. filed Critical Lg Life Sciences Ltd.

2004-09-30 Publication of IS7477A publication Critical patent/IS7477A/is

2011-04-15 Publication of IS2731B publication Critical patent/IS2731B/is

Links

239000002253 acid Substances 0.000 title 1
ZRCVYEYHRGVLOC-HYARGMPZSA-N gemifloxacin Chemical compound C1C(CN)C(=N/OC)/CN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1CC1 ZRCVYEYHRGVLOC-HYARGMPZSA-N 0.000 title 1
229960003170 gemifloxacin Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)

IS7477A 2002-04-08 2004-09-30 Aðferð til að framleiða sýrusölt af Gemifloxasíni IS2731B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR10-2002-0018847A KR100517638B1 (ko)	2002-04-08	2002-04-08	게미플록사신 산염의 새로운 제조방법
PCT/KR2003/000683 WO2003087100A1 (en)	2002-04-08	2003-04-04	Process for preparing acid salts of gemifloxacin

Publications (2)

Publication Number	Publication Date
IS7477A true IS7477A (is)	2004-09-30
IS2731B IS2731B (is)	2011-04-15

Family

ID=36241771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7477A IS2731B (is)	2002-04-08	2004-09-30	Aðferð til að framleiða sýrusölt af Gemifloxasíni

Country Status (31)

Country	Link
US (1)	US7361762B2 (is)
EP (1)	EP1497290B1 (is)
JP (1)	JP4315815B2 (is)
KR (1)	KR100517638B1 (is)
CN (1)	CN1291987C (is)
AP (1)	AP1786A (is)
AT (1)	ATE404559T1 (is)
AU (1)	AU2003219581B2 (is)
BR (1)	BRPI0309037B8 (is)
CA (1)	CA2481217C (is)
CO (1)	CO5611198A2 (is)
CY (1)	CY1108469T1 (is)
DE (1)	DE60322872D1 (is)
DK (1)	DK1497290T3 (is)
EA (1)	EA007222B1 (is)
ES (1)	ES2311694T3 (is)
GE (1)	GEP20074025B (is)
HR (1)	HRP20040929B1 (is)
IL (1)	IL164328A (is)
IS (1)	IS2731B (is)
MA (1)	MA26408A1 (is)
MX (1)	MXPA04009777A (is)
NO (1)	NO330042B1 (is)
NZ (1)	NZ536174A (is)
OA (1)	OA12801A (is)
PL (1)	PL372815A1 (is)
PT (1)	PT1497290E (is)
SI (1)	SI1497290T1 (is)
UA (1)	UA77070C2 (is)
WO (1)	WO2003087100A1 (is)
ZA (1)	ZA200408088B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100892864B1 (ko) *	2001-08-02	2009-04-15	주식회사 엘지생명과학	4-아미노메틸렌-피롤리딘-3-온의 아미노-보호 유도체및/또는 4-아미노메틸렌-피롤리딘-3-알콕시이미노유도체들 및/또는 제미플록사신 또는 그것의 염의 제조를위한 공정
WO2006134431A1 (en) *	2005-05-03	2006-12-21	Ranbaxy Laboratories Limited	Formate salt of gemifloxacin
EP2159225A1 (en) *	2005-06-15	2010-03-03	Hetero Drugs Limited	Gemifloxacin process and polymorphs
JP5384119B2 (ja) *	2006-03-07	2014-01-08	ウォックハートリミテッド	ベンゾキノリジン−２−カルボン酸のプロドラッグ
US20100076193A1 (en) *	2006-10-31	2010-03-25	Chandrasekaran Ramasubbu	process for the preparation of gemifloxacin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57134482A (en)	1981-02-13	1982-08-19	Dainippon Pharmaceut Co Ltd	1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (is)	1984-11-13	1988-07-09	Kyorin Seiyaku Kk
NZ222047A (en)	1986-10-08	1991-01-29	Bristol Myers Co	Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja)	1987-10-13	1989-04-18	Shionogi & Co Ltd	オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en)	1988-01-25	1990-04-24	Warner-Lambert Company	Antibacterial agents
JPH0356479A (ja)	1989-07-24	1991-03-12	Takeshi Yokota	水溶性キノロン誘導体のｐ‐トルエンスルホン酸塩
PL166381B1 (pl)	1989-08-16	1995-05-31	Pfizer	Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
US5137892A (en)	1990-12-12	1992-08-11	Abbott Laboratories	Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0541086A1 (en)	1991-11-08	1993-05-12	Kaken Pharmaceutical Co., Ltd.	Antibacterial 6-fluoro-quinolones having an oxime group on the substituent in position 7
JPH0673056A (ja)	1992-08-26	1994-03-15	Kaken Pharmaceut Co Ltd	キノリンカルボン酸誘導体およびその塩
US5776944A (en) *	1994-06-16	1998-07-07	Lg Chemical Ltd.	7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
DE69509442T2 (de)	1994-06-16	1999-09-02	Lg Chemical Ltd.	Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
JP3449658B2 (ja)	1994-12-21	2003-09-22	杏林製薬株式会社	安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
CA2223404C (en)	1995-06-06	2001-01-16	Thomas A. Morris	Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.\|-6-amino-3-azabicyclo¬3.1.0\|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
CZ296236B6 (cs)	1995-08-11	2006-02-15	Pfizer Inc.	Trihydrát methansulfonátu (1S,2S)-1-(4-hydroxyfenyl)-2-(4-hydroxy-4-fenylpiperidin-1-yl)-1-propanolu, farmaceutický prostredek a farmaceutická kombinace s jeho obsahem
UY24504A1 (es)	1996-03-29	1997-09-19	Smithkline Beecham Corp	Dihidrato de eprosartano y un procedimiento para su produccion y formulacion
MA24500A1 (fr) *	1997-03-21	1998-10-01	Lg Life Sciences Ltd	Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) *	1998-03-04	2001-04-16	성재갑	보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
DK1082300T3 (da)	1998-05-29	2003-12-15	Upjohn Co	3-[1'-N-Methylamino)ethyl-N-benzyl]pyrrolidin-monomethansulfonat
GB9820405D0 (en)	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
PT1223935E (pt)	1999-06-29	2008-04-03	Lg Life Sciences Ltd	Utilização de compostos de gemifloxacina contra bactérias
EP1401440A4 (en)	1999-09-01	2006-07-05	Lg Life Sciences Ltd	METHODS OF USING FLUOROQUINOLONE COMPOUNDS AGAINST BACTERIA
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
GB9920917D0 (en) *	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
AU7709400A (en)	1999-09-22	2001-04-24	Smithkline Beecham Corporation	Methods of use of fluoroquinolone compounds against bacteria
KR20010091379A (ko)	2000-03-15	2001-10-23	성재갑	7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko)	2000-09-01	2002-03-08	성재갑	3-아미노메틸-4-ｚ-메톡시이미노피롤리딘의 신규 제조방법

2002
- 2002-04-08 KR KR10-2002-0018847A patent/KR100517638B1/ko not_active Expired - Lifetime
2003
- 2003-04-04 HR HRP20040929AA patent/HRP20040929B1/hr not_active IP Right Cessation
- 2003-04-04 NZ NZ536174A patent/NZ536174A/en not_active IP Right Cessation
- 2003-04-04 AT AT03715805T patent/ATE404559T1/de active
- 2003-04-04 JP JP2003584056A patent/JP4315815B2/ja not_active Expired - Fee Related
- 2003-04-04 AU AU2003219581A patent/AU2003219581B2/en not_active Ceased
- 2003-04-04 BR BRPI0309037A patent/BRPI0309037B8/pt not_active IP Right Cessation
- 2003-04-04 AP APAP/P/2004/003148A patent/AP1786A/en active
- 2003-04-04 SI SI200331341T patent/SI1497290T1/sl unknown
- 2003-04-04 WO PCT/KR2003/000683 patent/WO2003087100A1/en not_active Ceased
- 2003-04-04 GE GEAP8436A patent/GEP20074025B/en unknown
- 2003-04-04 ES ES03715805T patent/ES2311694T3/es not_active Expired - Lifetime
- 2003-04-04 EP EP03715805A patent/EP1497290B1/en not_active Expired - Lifetime
- 2003-04-04 CN CNB038095483A patent/CN1291987C/zh not_active Expired - Lifetime
- 2003-04-04 MX MXPA04009777A patent/MXPA04009777A/es active IP Right Grant
- 2003-04-04 UA UA20041008144A patent/UA77070C2/uk unknown
- 2003-04-04 OA OA1200400271A patent/OA12801A/en unknown
- 2003-04-04 US US10/510,514 patent/US7361762B2/en not_active Expired - Lifetime
- 2003-04-04 CA CA2481217A patent/CA2481217C/en not_active Expired - Lifetime
- 2003-04-04 PL PL03372815A patent/PL372815A1/xx not_active Application Discontinuation
- 2003-04-04 EA EA200401328A patent/EA007222B1/ru not_active IP Right Cessation
- 2003-04-04 DK DK03715805T patent/DK1497290T3/da active
- 2003-04-04 DE DE60322872T patent/DE60322872D1/de not_active Expired - Lifetime
- 2003-04-04 PT PT03715805T patent/PT1497290E/pt unknown
2004
- 2004-09-30 IS IS7477A patent/IS2731B/is unknown
- 2004-10-05 CO CO04099283A patent/CO5611198A2/es active IP Right Grant
- 2004-10-07 MA MA27894A patent/MA26408A1/fr unknown
- 2004-10-07 ZA ZA200408088A patent/ZA200408088B/xx unknown
- 2004-10-21 IL IL164328A patent/IL164328A/en unknown
- 2004-10-27 NO NO20044629A patent/NO330042B1/no not_active IP Right Cessation
2008
- 2008-10-31 CY CY20081101234T patent/CY1108469T1/el unknown

Also Published As

Publication number	Publication date
HK1074440A1 (en)	2005-11-11
CY1108469T1 (el)	2014-04-09
IL164328A0 (en)	2005-12-18
EP1497290B1 (en)	2008-08-13
CO5611198A2 (es)	2006-02-28
MXPA04009777A (es)	2004-12-13
SI1497290T1 (sl)	2008-12-31
KR100517638B1 (ko)	2005-09-28
DE60322872D1 (de)	2008-09-25
MA26408A1 (fr)	2004-12-01
US20050148622A1 (en)	2005-07-07
CN1649868A (zh)	2005-08-03
JP4315815B2 (ja)	2009-08-19
NO20044629L (no)	2004-10-27
AP1786A (en)	2007-10-04
BRPI0309037B1 (pt)	2018-07-31
ATE404559T1 (de)	2008-08-15
AU2003219581A1 (en)	2003-10-27
ES2311694T3 (es)	2009-02-16
ZA200408088B (en)	2006-05-31
WO2003087100A1 (en)	2003-10-23
CA2481217C (en)	2010-06-01
DK1497290T3 (da)	2008-12-15
AP2004003148A0 (en)	2004-12-31
KR20030080292A (ko)	2003-10-17
CN1291987C (zh)	2006-12-27
OA12801A (en)	2006-07-11
EP1497290A4 (en)	2006-05-10
BRPI0309037B8 (pt)	2021-05-25
PT1497290E (pt)	2008-11-14
PL372815A1 (en)	2005-08-08
AU2003219581B2 (en)	2006-08-24
GEP20074025B (en)	2007-01-25
NO330042B1 (no)	2011-02-07
HRP20040929A2 (en)	2005-02-28
EA007222B1 (ru)	2006-08-25
HRP20040929B1 (hr)	2013-12-06
EA200401328A1 (ru)	2005-06-30
US7361762B2 (en)	2008-04-22
EP1497290A1 (en)	2005-01-19
IS2731B (is)	2011-04-15
IL164328A (en)	2009-08-03
JP2005529112A (ja)	2005-09-29
BR0309037A (pt)	2005-02-01
UA77070C2 (uk)	2006-10-16
NZ536174A (en)	2006-09-29
CA2481217A1 (en)	2003-10-23

Publication	Publication Date	Title
DK1539711T3 (da)	2011-05-30	Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
NO20053796D0 (no)	2005-08-11	Process for the production of particles
EP1469027A4 (en)	2007-01-10	METHOD FOR CONTINUOUS PRODUCTION OF POLYETHERES
DK1592401T3 (da)	2012-05-21	Fremgangsmåde til ændring af medikamentkrystaldannelsen af mycophenolat-natriumsalt
IL183591A0 (en)	2007-09-20	Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
EE200300343A (et)	2003-10-15	Pantoteenhappe võimendatud produktsiooni meetod
HRP20150163T1 (xx)	2015-03-27	Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
NO20054694D0 (no)	2005-10-12	Fremgangsmate for fremstilling av eddiksyre
PL371629A1 (pl)	2005-06-27	Sposób wytwarzania kombrestatyn
IS8416A (is)	2006-04-12	Aðferð við framleiðslu á CCR-2 mótlyfi
DK1682541T3 (da)	2010-06-28	Fremgangsmåde til fremstilling af tiotropiumsalte
DE602004021052D1 (de)	2009-06-25	Herstellungsverfahren von Xylylendiamin
ATE465155T1 (de)	2010-05-15	Verfahrensherstellung von ethern
IS7477A (is)	2004-09-30	Aðferð við framleiðslu sýrusalts af gemifloxasíni
IL176286A0 (en)	2006-10-05	Production of dihydronepetalactone by reduction of nepetalic acid
EP1539703A4 (en)	2007-02-21	METHOD FOR SELECTIVELY PREPARING A 3-OXO-4-AZA-5A ANDROSTAN COMPOUND
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
IS8333A (is)	2006-02-28	Aðferð við framleiðslu á THIP
FR2869030B1 (fr)	2006-11-10	Procede de production d'alpha-alumine particulaire
EP1650185A4 (en)	2007-06-20	METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-HYDROXY-ALPHA-AMINOCARBOXYLIC ACID DERIVATIVES
DK1656340T3 (da)	2012-10-01	Fremgangsmåde til fremstilling af 1-carbamoylcykloalkylcarboxylsyreforbindelser
FR2835839B1 (fr)	2004-04-02	Procede de preparation de la 7beta-hydroxy-dehydroepiandrosterone
IL162756A0 (en)	2005-11-20	Process for production of dimethyl-2-formylcyclopropanecarboxylic acid derivatives
FI20021510L (fi)	2004-02-22	Karboksyylihapon suolojen valmistusprosessi